The Tracking Study

In July 2006 we began to look for volunteers to help us with the Tracking Study. This involved following a CF patient during a period of lung exacerbation, whilst they were having their IV antibiotics as in-patients (or if they lived locally, at home).

We took various assays from patients during this study, the results of which showed us whether a change in the assays corresponded with any clinical improvement seen in patients. We recruited 46 volunteers aged 12 and above between the London and Edinburgh sites.

The study involved requesting a few samples such as sputum and blood and asking the participant to undertake some tests such as a CT scan, exhaled breathe condensate, multiple breath washout, spirometry and nasal potential difference.

These tests were done in hospital, primarily on the first and last day of admission/course of IV antibiotics and at the follow up appointment.

  • pGM169

    Find out more about the production of our first clinical product

  • Lab slides

    Find out more about the Tracking Study in 2006

  • Lung Function Test

    Find out more about the preparation for the multi dose trial

  • Staged Nebuliser Delivery

    Find our more about the Single Dose Clinical Trial that started in 2009

  • Staged Gas Transfer

    Find out more about the Multi Dose Trial, following on from the Single Dose Clinical Trial

  • Eric Alton

    Watch the results presentation given by Prof. Eric Alton on 30 May 2015

Find out about the discovery of

the CFTR Gene,

responsible for Cystic Fibrosis

Find out how

the CFTR Gene

causes Cystic Fibrosis

Find out about

the structure of the

CFTR Protein

Why use Gene Therapy

to treat

Cystic Fibrosis?

Contact  |  About  |  Jobs  |  Publications

  • White Facebook Icon
  • White Twitter Icon

©UK Respiratory Gene Therapy Consortium |  Terms of Use  |   Privacy Policy   |   Accessibility